Clinical and Angiographic Follow-Up of Small Vessel Lesions Treated With Paclitaxel-Eluting Stents (from the TRUE Registry)

Cosmo Godino, Shinichi Furuichi, Azeem Latib, Nuccia Morici, Alaide Chieffo, Enrico Romagnoli, Corrado Tamburino, Rossella Barbagallo, Michela Cera, David Antoniucci, Omer Goktekin, Carlo Di Mario, Bernard Reimers, Eberhard Grube, Flavio Airoldi, Giuseppe M. Sangiorgi, Antonio Colombo

Research output: Contribution to journalArticle

Abstract

Several randomized trials have shown that sirolimus-eluting stents and paclitaxel-eluting stents (PES) are effective in reducing restenosis in respect to bare-metal stents, including the subset of small vessels. The objective of this study was to evaluate "real world" angiographic and clinical outcomes of a large series of patients enrolled in the TRUE registry and treated with PES for both small vessel and very small vessel lesions. A consecutive series of 675 patients (926 lesions) with reference vessel diameter

Original languageEnglish
Pages (from-to)1002-1008
Number of pages7
JournalThe American Journal of Cardiology
Volume102
Issue number8
DOIs
Publication statusPublished - Oct 15 2008

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Clinical and Angiographic Follow-Up of Small Vessel Lesions Treated With Paclitaxel-Eluting Stents (from the TRUE Registry)'. Together they form a unique fingerprint.

  • Cite this

    Godino, C., Furuichi, S., Latib, A., Morici, N., Chieffo, A., Romagnoli, E., Tamburino, C., Barbagallo, R., Cera, M., Antoniucci, D., Goktekin, O., Di Mario, C., Reimers, B., Grube, E., Airoldi, F., Sangiorgi, G. M., & Colombo, A. (2008). Clinical and Angiographic Follow-Up of Small Vessel Lesions Treated With Paclitaxel-Eluting Stents (from the TRUE Registry). The American Journal of Cardiology, 102(8), 1002-1008. https://doi.org/10.1016/j.amjcard.2008.05.052